IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) Imricor's vision is to bring iMR to every cardiac centre in the world WWW.IMRICOR.COM 1H 2026 Investor Presentation 1 August 10 th 2026 Disclaimer WWW.IMRICOR.COM IMRICOR MEDICAL SYSTEMS, INC (ASX:IMR) 2 The material contained in this ...
1H 2026 Investor Presentation
Filed with ASX · · 28 pages · English
Summary by 6ix AI
The presentation discusses regulatory progress, including FDA clearances and clinical trial updates, emphasizing the company's advancements in cardiac imaging technology. It also highlights the company's financial performance, including cash balances and operating expenses, while projecting future growth in the catheter ablation market.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Imricor Medical Systems, Inc. on 6ix
In the deck
Earlier from Imricor Medical Systems
- 2026 Q2 Form 10-Q
- Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission
- Philips Declares Compatibility with Imricor
- Q2 FY26 Results Webinar Notification
Later from Imricor Medical Systems
- Imricor U.S. Commercial Momentum Accelerates
- Imricor and Philips Launch Commercial iMR Lab Solution
- Release from Voluntary Escrow
- FDA Accepts Imricor PMA Manufacturing Module
- S&P DJI Announces September 2026 Quarterly Rebalance
Follow Imricor Medical Systems into a list and get an email when it puts out news.
Follow Imricor Medical Systems